Jessica Fioravanti

4PUBLICATIONS
20CO-AUTHORS
Haematological tumoursSensory processes, perception and performanceApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 08, 2024
LIM-domain-only 4 (LMO4) enhances CD8+ T-cell stemness and tumor rejection by boosting IL-21-STAT3 signaling.

Roland C Schelker, Jessica Fioravanti, Fabio Mastrogiovanni

|Jun 19, 2019
Single-cell RNA-seq reveals TOX as a key regulator of CD8+ T cell persistence in chronic infection.

Chen Yao, Hong-Wei Sun, Neal E Lacey

|May 16, 2019
miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate.

Yun Ji, Jessica Fioravanti, Wei Zhu

|Feb 20, 2019
The transcription factor c-Myb regulates CD8+ T cell stemness and antitumor immunity.

Sanjivan Gautam, Jessica Fioravanti, Wei Zhu

Pageof 1

Frequent Collaborators

4 joint publications

Luca Gattinoni

3 joint publications

Neal E Lacey

2 joint publications

Yun Ji

1 joint publications

Hai-Hui Xue